Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/1999
07/21/1999EP0929675A2 Nucleotide and protein sequence of mammastatin and methods of use
07/21/1999EP0929674A2 HUMAN Bad POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE
07/21/1999EP0929672A1 Human gtp binding protein gamma-3
07/21/1999EP0929667A1 Hypertension markers
07/21/1999EP0929665A1 Cell-based drug screens for regulators of gene expression
07/21/1999EP0929579A1 Monoclonal antibodies against a human act and serine protease complex
07/21/1999EP0929575A1 Novel human growth factors
07/21/1999EP0929573A1 Methods for the isolation and proliferation of insulin-secreting cells
07/21/1999EP0929311A1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1 beta-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS
07/21/1999EP0575515B1 Stabilization of enzyme containing reagent composition for determination of an analyte
07/21/1999EP0463064B1 Neuronal nicotinic acetylcholine receptor compositions containing the beta4 subunit
07/21/1999CN1223692A Analyte assy using particulate labels
07/21/1999CN1223688A Plant gene for p-hydroxyphenylpyruvate dioxygenase
07/21/1999CN1223687A Isolation of the biosythesis genes for pseudo-oligosaccharides from streptomyces glaucescens gla.o and their use
07/21/1999CN1223685A Modulators of tissue regeneration
07/20/1999US5925807 GA4 DNA, protein and method of use
07/20/1999US5925751 Human cytomegalovirus DNA sequences
07/20/1999US5925750 Nucleic acid encoding polypeptide of a growth factor receptor family
07/20/1999US5925748 DNA diagnostics for glaucoma
07/20/1999US5925744 Macrocyclic compound for sequence cleavage of rna
07/20/1999US5925740 Antibodies to receptor for oncostatin M
07/20/1999US5925733 DNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retroperitoneal fibromatosis
07/20/1999US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology
07/20/1999US5925571 Method of testing immune competency
07/20/1999US5925558 Assays for protein kinases using fluorescent protein substrates
07/20/1999US5925547 Nucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteins
07/20/1999US5925539 Human pelota homolog
07/20/1999US5925536 Receptor-type phosphotyrosine phosphatase-β
07/20/1999US5925534 Method for measuring LDL-cholesterol
07/20/1999US5925532 Enhancing the sensitivity of immunoassay procedures by use of antibodies directed to the product of a reaction between probe labels and assay substrates
07/20/1999US5925529 The inventive detection system involves the use of a ?tethered? ligand for probing receptor binding.
07/20/1999US5925525 Method of identifying nucleotide differences
07/20/1999US5925524 In vitro assay for carcinogens using phenotypic transformation of human cells
07/20/1999US5925523 Intraction trap assay, reagents and uses thereof
07/20/1999US5925522 Salmonella nucleotide sequences, methods of detection of salmonella nucleotide sequences, and method of detection of salmonella
07/20/1999US5925521 Human serine carboxypeptidase
07/20/1999US5925520 Incorporating fluorescently labeled chain terminators complementary to target bases into primers adapted by size to increase separation, then separating extended primers based on size or charge, identifying terminators
07/20/1999US5925519 Genetic alterations associated with prostate cancer
07/20/1999US5925518 Nucleic acid primers for amplification of a mycobacteria RNA template
07/20/1999US5925517 Hybridization probe of single-stranded sequence complementary to target, flanked by oligonucleotide arms with interacting labels capable of forming stem duplex; hybridization with target alters level of signal at least ten percent
07/20/1999US5925516 Medicaments for the treatment of papillomavirus diseases
07/20/1999US5925512 Monoclonal antibody which specifically binds to mutant hepatitis b virus surface antigen ?a? determinant
07/20/1999US5925352 Administering antiinflammatory amount of anti-neutrophil chemotactic factor antibodies
07/20/1999CA2184105C Nucleic acid amplification using a reversibly inactivated thermostable enzyme
07/20/1999CA2087730C Use of crosslinked crystals as a novel form of enzyme immobilization
07/15/1999WO1999035502A1 Use of mass fingerprinting for identification of protein affinity ligands
07/15/1999WO1999035499A1 Method comprising capture molecule fixed on disc surface
07/15/1999WO1999035494A1 Method for identifying validated target and assay combinations
07/15/1999WO1999035493A1 Screening method for apoptosis and necrosis
07/15/1999WO1999035487A1 Methods and apparatus for accurate analysis of bodily fluid constituents
07/15/1999WO1999035482A1 A method and an arrangement for measuring the amount/activity of catalase before or in connection with bleaching of preferably cellulose fibres included in a pulp suspension
07/15/1999WO1999035293A2 Solid phase selection of differentially expressed genes
07/15/1999WO1999035292A1 Compositions and methods for treating cells having double minute dna
07/15/1999WO1999035291A1 Isothermal transcription based amplification assay for the detection and quantitation of macrophage derived chemokine rna
07/15/1999WO1999035290A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
07/15/1999WO1999035289A1 Polymeric arrays and methods for their use in binding assays
07/15/1999WO1999035288A1 Enzyme-specific cleavable polynucleotide substrate and assay method
07/15/1999WO1999035287A1 Probes for detecting target nucleic acid, method of detecting target nucleic acid, and solid phase for detecting target nucleic acid and process for producing the same
07/15/1999WO1999035286A2 Assay for predicting the angiographic response to lipid-lowering therapy in patients
07/15/1999WO1999035285A2 Hybridization probes which differentiate between the actinomadura madurae group of bacteria and maduromycetes
07/15/1999WO1999035284A1 A method for the diagnosis, identification and characterization of m. tuberculosis and other mycobacteria by shift mobility assay
07/15/1999WO1999035281A1 Method for in vitro amplification of circular dna
07/15/1999WO1999035279A1 G protein-related kinase mutants in essential hypertension
07/15/1999WO1999035277A2 Recombinant, active caspases and uses thereof
07/15/1999WO1999035266A2 Human urotensin ii
07/15/1999WO1999035265A1 Human vps35/mem3-related protein
07/15/1999WO1999035263A2 Il-17rh dna and polypeptides
07/15/1999WO1999035262A2 Apoptosis inducing molecule ii
07/15/1999WO1999035261A1 Novel gene having reverse transcriptase motif
07/15/1999WO1999035259A1 Identification of lysolipid receptors involved in inflammatory response
07/15/1999WO1999035258A1 Nucleic acid markers for apospory-specific genomic region
07/15/1999WO1999035257A1 Target for treating atherosclerosis, obesity and type ii diabetes
07/15/1999WO1999035256A1 Screening interactor molecules with whole genome oligonucleotide or polynucleotide arrays
07/15/1999WO1999035253A1 Secreted proteins and polynucleotides encoding them
07/15/1999WO1999035252A2 Secreted proteins and polynucleotides encoding them
07/15/1999WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor
07/15/1999WO1999035165A1 Secreted proteins and polynucleotides encoding them
07/15/1999WO1999035159A1 Lymphoma/leukemia oncogene, oncoprotein and methods of use
07/15/1999WO1999035106A2 Mammalian edg-7 receptor homologs
07/15/1999WO1999034984A1 Labeling technique for countering product diversion and product counterfeiting
07/15/1999WO1999034806A1 KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA)
07/15/1999WO1999034781A1 Brain aging assay
07/15/1999WO1999028466A8 Compositions and methods of use of het
07/15/1999WO1999026070A3 Method for automatic implementation of chemical or biological methods
07/15/1999WO1999024612A3 Multiple sequential polynucleotide displacement reactions for signal amplification and processing
07/15/1999WO1999024602A3 Process for determining cell vitality and efficiency in parallel
07/15/1999WO1999023245A8 Method for enzyme assay
07/15/1999WO1999023232B1 Glyphosate resistant transgenic plants
07/15/1999WO1999022022A3 Test procedure for identifying persons with defective mismatch repair systems
07/15/1999WO1999022020A3 Labelling of polymers and sequencing of nucleic acids
07/15/1999DE19801090A1 Device for isolating of microorganisms from cell-containing fluids using standard syringes
07/15/1999CA2325049A1 Mammalian edg-7 receptor homologs
07/15/1999CA2324972A1 Identification of lysolipid receptors involved in inflammatory response
07/15/1999CA2318380A1 Compositions and methods for treating cells having double minute dna
07/15/1999CA2318369A1 Recombinant, active caspases and uses thereof
07/15/1999CA2317940A1 Assay for predicting the angiographic response to lipid-lowering therapy in patients
07/15/1999CA2317898A1 Human vps35/mem3-related protein
07/15/1999CA2317897A1 Hybridization probes which differentiate between the actinomadura madurae group of bacteria and maduromycetes
07/15/1999CA2317817A1 Il-17rh dna and polypeptides
07/15/1999CA2317695A1 Solid phase selection of differentially expressed genes